MX370585B - Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico. - Google Patents

Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.

Info

Publication number
MX370585B
MX370585B MX2016007309A MX2016007309A MX370585B MX 370585 B MX370585 B MX 370585B MX 2016007309 A MX2016007309 A MX 2016007309A MX 2016007309 A MX2016007309 A MX 2016007309A MX 370585 B MX370585 B MX 370585B
Authority
MX
Mexico
Prior art keywords
anthelmintic
treatment method
composition
preparing
anthelmintic composition
Prior art date
Application number
MX2016007309A
Other languages
English (en)
Other versions
MX2016007309A (es
Inventor
Coraucci Neto Dolivar
Neto Zampier Maira
Caetano Monti Guedes Rodrigo
Original Assignee
Ouro Fino Saude Animal Participacoes S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Saude Animal Participacoes S A filed Critical Ouro Fino Saude Animal Participacoes S A
Publication of MX2016007309A publication Critical patent/MX2016007309A/es
Publication of MX370585B publication Critical patent/MX370585B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición anti-helmíntica inyectable de avermectina y sulfóxido de Albendazol base para usarse en el combate de parásitos que atacan animales; la invención contempla, aún, un proceso específico que permite la asociación estable de avermectina y sulfóxido de albendazol base.
MX2016007309A 2013-12-05 2014-12-04 Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico. MX370585B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102013031277A BR102013031277B1 (pt) 2013-12-05 2013-12-05 processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável
PCT/BR2014/000426 WO2015081401A1 (pt) 2013-12-05 2014-12-04 Processo para preparar uma composição anti-helmíntica, composição anti-helmíntica, método de tratamento veterinário e método de tratamento anti-helmíntico

Publications (2)

Publication Number Publication Date
MX2016007309A MX2016007309A (es) 2017-03-09
MX370585B true MX370585B (es) 2019-12-17

Family

ID=53272660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007309A MX370585B (es) 2013-12-05 2014-12-04 Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.

Country Status (6)

Country Link
US (1) US10052341B2 (es)
AR (1) AR098630A1 (es)
AU (1) AU2014360618A1 (es)
BR (1) BR102013031277B1 (es)
MX (1) MX370585B (es)
WO (1) WO2015081401A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375205B (zh) * 2017-07-31 2019-11-08 佛山市南海东方澳龙制药有限公司 非油性多拉菌素注射液及其制备方法和应用
CN111920807B (zh) * 2020-08-24 2022-10-04 吴蕾 阿苯达唑包合物及其超声波法制备工艺
BR102020021181A2 (pt) 2020-10-16 2022-04-26 Ipanema Industria De Produtos Veterinarios Ltda Microssuspensão contra parasitas e método para sua obtenção
CN113214163B (zh) * 2021-04-30 2023-03-14 青海大学 一种阿苯达唑-胆酸衍生物及其制备方法和应用
CN114917221A (zh) * 2022-05-27 2022-08-19 吉林吉力生物技术研究有限公司 一种兽用阿苯哒唑亚砜组合物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
JP5342239B2 (ja) * 2005-12-06 2013-11-13 ゾエティス・ダブリュー・エルエルシー ベンジイミダゾール非水性組成物
BRPI0506279B1 (pt) * 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
CN1839864A (zh) * 2006-01-20 2006-10-04 长治奥凯得日化有限责任公司 复方阿维菌素注射液
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais
AU2011252987B2 (en) * 2010-05-12 2013-05-02 Boehringer Ingelheim Animal Health USA Inc. Injectable parasiticidal formulations of levamisole and macrocyclic lactones
CN102258529B (zh) * 2011-04-29 2013-02-13 长沙施比龙动物药业有限公司 一种复方伊维菌素注射液及其制备方法
CN102440996B (zh) * 2011-12-29 2013-04-24 郑国祥 含有伊维菌素纳米乳的复方阿苯达唑混悬液及其制备方法

Also Published As

Publication number Publication date
MX2016007309A (es) 2017-03-09
US10052341B2 (en) 2018-08-21
WO2015081401A1 (pt) 2015-06-11
BR102013031277A2 (pt) 2015-11-10
AR098630A1 (es) 2016-06-01
AU2014360618A1 (en) 2016-07-14
BR102013031277B1 (pt) 2018-10-02
US20160303157A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
IL264413B (en) Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PH12016500582A1 (en) Heterocyclic compounds and uses thereof
MX2016013689A (es) Compuestos 4-amino-imidazoquinolina.
CL2015000543A1 (es) Derivados de alcanediil y alcanediil-c17, de ácido oleanólico compuestos intermediarios, composición parmacéutica y métodos asociados.
NI201600071A (es) Compuestos de inhibidor de autotaxina
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
CL2015001389A1 (es) Composiciones y compuestos antihelmínticos y métodos para usarlos.
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
MX2016004035A (es) Formulaciones de espiro-isoxazolina de accion prolongada.
PH12016502003B1 (en) Novel bacteriophage and composition containing same
MX2016007309A (es) Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
BR112017000730A2 (pt) derivados de pirrolidinona como inibidores de metap-2
CL2018001493A1 (es) Nuevos derivados de fenilo
PH12016501999B1 (en) Novel bacteriophage and composition containing same
BR112017008481A2 (pt) composto antimicótico
TN2015000440A1 (en) Alpha-2 adrenoceptor and sigma receptor ligand combinations
PH12016502001B1 (en) Novel bacteriophage and composition comprising same
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
PE20170770A1 (es) Metodos y composiciones para tratar trastornos relacionados con vih

Legal Events

Date Code Title Description
FG Grant or registration